Glycomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented By Product Type (Enzymes, Analysis Kits, Reagents, and Instruments), Application (Drug Development, Diagnostics, and Other Applications) and Geography.

Market Snapshot

Glycomics Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.9 %
Glycomics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The glycomics market is expected to register a CAGR of 13.9% during the forecast period with the increasing research and development activities about glycomes and emerging technology for analysis of glycans and proteomes. Glycans, generally present on the cell surface, plays a very crucial role in the body system. They are responsible for many hereditary diseases and has a vital role in cancer development. Erythropoietin is a biological product used in anti-viral therapy and has three N-glycans and one O-glycan chain. Furthermore, in 2017, Sciex launched “Fast Glycan Labelling and Analysis Kit.” It saves time and effort for sample preparation, mostly used in the quantitative estimation of N-glycan. Hence, these factors are expected to drive the glycomics market growth. But the high cost of products related to glycomes may obstruct the glycomes market growth.

Scope of the Report

As per the scope of the report, Glycomics is the study of glycomes, a sugar chain found in organisms either as a free chain or as a complex molecule. Glycomics is a subset of the field of glycobiology that aims to identify the structure and function of the complete set of glycans (the glycome) produced in a given cell or organism and identify all the genes that encode glycoproteins. Glycomics market is segmented by product type, applications, and geography. Instruments such as HPLC, Mass spectroscopy microarrays along with the reagents used in the glycomic analysis are being tracked in the report.

By Product Type
Instruments
Reagents and Kits
Enzymes
By Application
Drug Development
Diagnostics
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Discovery and Development Segment is Expected to Hold a Major Market Share in the Glycomics Market

  • As the burden of chronic diseases is increasing, the need for developing new drugs is also increasing. Glycans play a major role in biological processes such as cell-cell interaction and thus have immense importance in drug development. Therefore, often these glycan chains are modified to synthesize drugs. For instance, hyaluronan, a naturally occurring disaccharide unit of glycosaminoglycan, has wide applications into medicine. It is used in post-surgical wounds and has an essential part in osteoarthritis treatment.
  • Furthermore, glycans have wide applications in vaccine development too. Many of the conjugate vaccines are based upon proteins and glycans. For instance, Prevnar 13 (manufactured by Pfizer, Inc.) used for preventing pneumococcal bacterial infection, is based upon glycans.
  • Thus, considering rising research and development, the market is expected to witness healthy CAGR over the forecast period.
Glycomics Market Share

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the glycomics market owing to increasing research and development activities and government funding programs. Recently, the National Institute of Health-funded into the research “Computational and Informatics Resources and Tools for Glycoscience Research.” Furthermore, companies are investing heavily in research and development activities, which are expected to propel the growth of glycomics. According to Pharmaceutical Research and Manufacturers of America, in 2018, the pharmaceutical industry spent over USD 79.6 billion on research and development. Thus, it is expected to impact positively on North America’s glycomics market.

Glycomics Market Analysis

Competitive Landscape

The glycomics market is fragmented and consists of several major players. Companies are adopting growth strategies in order to develop the glycomics market. For instance, in 2018, Agilent Technologies, Inc. acquired ProZyme, Inc. to expand its product-line into glycome products. ProZyme Inc. is known for its glycobiology products and bioanalytical proteins. Some of the companies which are currently dominating the market are ThermoFisher Scientific Inc., Agilent Technologies Inc., Merck KGaA, Bruker, New England Biolabs Inc., Danaher (SCIEX), Takara Bio Inc., Waters Corporation, QA-Bio, and Shimadzu Corporation.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Research and Development Activities in Glycomics

      2. 4.2.2 Technological Advancements in Products

    3. 4.3 Market Restraints

      1. 4.3.1 Complexity of Glycomics Coupled With The High Cost Involved in the Process

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents and Kits

      3. 5.1.3 Enzymes

    2. 5.2 By Application

      1. 5.2.1 Drug Development

      2. 5.2.2 Diagnostics

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 ThermoFisher Scientific Inc.

      2. 6.1.2 Agilent Technologies Inc.

      3. 6.1.3 Merck KGaA

      4. 6.1.4 Bruker

      5. 6.1.5 New England Biolabs Inc.

      6. 6.1.6 Danaher (SCIEX)

      7. 6.1.7 Takara Bio Inc.

      8. 6.1.8 Waters Corporation

      9. 6.1.9 QA-Bio

      10. 6.1.10 Shimadzu Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Glycomics Market market is studied from 2018 - 2026.

The Glycomics Market is growing at a CAGR of 13.9% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

ThermoFisher Scientific Inc. - , Merck KGaA, New England Biolabs, Inc., Agilent Technologies, Inc., Takara Bio Inc. are the major companies operating in Glycomics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!